[Federal Register Volume 67, Number 10 (Tuesday, January 15, 2002)]
[Notices]
[Page 1990]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-935]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated July 13, 2001, and published in the Federal 
Register on July 23, 2001 (66 FR 38323), Abbott Laboratories, DBA Knoll 
Pharmaceutical Company, 30 North Jefferson Road, Whippany, New Jersey 
07981, made application to the Drug Enforcement Administration to be 
registered as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Dihydromorphine (9145).....................  I
Hydromorphone (9150).......................  II
------------------------------------------------------------------------

    The firm plans to produce bulk product and finished dosage units 
for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Abbott Laboratories to manufacture 
the listed controlled substances is consistent with the public interest 
at this time. DEA has investigated Abbott Laboratories to ensure that 
the company's registration is consistent with the public interest. This 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Deputy Assistant Administrator, Office of Diversion Control, 
hereby orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed above is granted.

    Dated: January 4, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-935 Filed 1-14-02; 8:45 am]
BILLING CODE 4410-09-M